Related references
Note: Only part of the references are listed.Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors
Nunghathai Sawasdee et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2022)
cFLIP downregulation is an early event required for endoplasmic reticulum stress-induced apoptosis in tumor cells
Rocio Mora-Molina et al.
CELL DEATH & DISEASE (2022)
Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
Methi Wathikthinnakon et al.
SCIENTIFIC REPORTS (2022)
NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations
Carlos E. Sanchez et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
Suthida Panwong et al.
MOLECULES (2021)
Strategies to sensitize cancer cells to immunotherapy
Andrew George et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Immunotherapy in cholangiocarcinoma: From concept to clinical trials
Wen-Yan Yao et al.
SURGERY IN PRACTICE AND SCIENCE (2021)
Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence
Shian-Ren Lin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies
Sarina A. Piha-Paul et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer
Christian Sordo-Bahamonde et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look
Angela Dalia Ricci et al.
CANCER CONTROL (2020)
Mechanisms of natural killer cell-mediated cellular cytotoxicity
Isabel Prager et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing
Isabel Prager et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
Kyle B. Lupo et al.
CANCERS (2019)
Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation
Sang R. Lee et al.
BMC CANCER (2019)
The role of tumour microenvironment: a new vision for cholangiocarcinoma
Ziyan Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances
Hardeep Singh Tuli et al.
FRONTIERS IN PHARMACOLOGY (2019)
Immunobiology of cholangiocarcinoma
Emilien Loeuillard et al.
JHEP REPORTS (2019)
Cholangiocarcinoma - evolving concepts and therapeutic strategies
Sumera Rizvi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer
Andre Steven et al.
BREAST CARE (2018)
Genistein reduces the activation of AKT and EGFR, and the production of IL6 in cholangiocarcinoma cells involving estrogen and estrogen receptors
Pariyada Tanjak et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress-related autophagy in hepatocellular carcinoma
Dong Liu et al.
ONCOLOGY REPORTS (2018)
The Influence of Metabolism on Drug Response in Cancer
Esther A. Zaal et al.
FRONTIERS IN ONCOLOGY (2018)
Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
Kai-chao Feng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells
Svenja Sydor et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy
Brent A. Williams et al.
ONCOTARGET (2017)
Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells
Gianluca Carnevale et al.
SCIENTIFIC REPORTS (2017)
Forty-Year Trends in Cholangiocarcinoma Incidence in the US: Intrahepatic Disease on the Rise
Supriya K. Saha et al.
ONCOLOGIST (2016)
Genistein induces apoptosis and autophagy in human breast MCF-7 cells by modulating the expression of proapoptotic factors and oxidative stress enzymes
R. F. Prietsch et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells
Dhifaf Sarhan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling
Erik Wennerberg et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells
Zhiyu Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Dendritic Cell-Based Immunotherapy Targeting Synthesized Peptides for Advanced Biliary Tract Cancer
Masanori Kobayashi et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Induction of Apoptosis in HeLa Cells via Caspase Activation by Resveratrol and Genistein
Sivanesan Dhandayuthapani et al.
JOURNAL OF MEDICINAL FOOD (2013)
Effects of bortezomib in sensitizing human prostate cancer cell lines to NK-mediated cytotoxicity
Wei Hu et al.
ASIAN JOURNAL OF ANDROLOGY (2012)
Estrogen is increased in male cholangiocarcinoma patients' serum and stimulates invasion in cholangiocarcinoma cell lines in vitro
Taweewun Hunsawong et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation
Xiaoping Yu et al.
MEDICAL ONCOLOGY (2012)
Sensitization of Cervical Cancer Cells to Cisplatin by Genistein: The Role of NF kappa B and Akt/mTOR Signaling Pathways
K. Sahin et al.
JOURNAL OF ONCOLOGY (2012)
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
Jeffrey E. Rubnitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sensitization of human breast cancer cells to natural killer cell-mediated cytotoxicity by proteasome inhibition
E. Ames et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells
Zhong Li et al.
CELL BIOLOGY AND TOXICOLOGY (2008)
Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition
William H. D. Hallett et al.
JOURNAL OF IMMUNOLOGY (2008)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma
MP Oyarzo et al.
BLOOD (2006)
Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100)
Banchob Sripa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines
Nisana Tepsiri et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein (TM)) in healthy volunteers
U Ullmann et al.
ADVANCES IN THERAPY (2005)
c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis
DW Chang et al.
EMBO JOURNAL (2002)